The biggest risks show up when theres no monitoring: fluid retention, shifts in blood sugar, or insulin resistance that build quietly over time
Diabetics on insulin or sulfonylureas without medical supervision
Reach out to a qualified healthcare provider to build a personalized plan that addresses your unique metabolic needs, helps manage side effects, and keeps you on track toward your wellness goals safely and effectively.
On the contrary, a recent study showed that alogliptin treatment (10 mg/kg/d for 10 weeks) did not benefit the rats from high-cho diet (2.0%)-induced changes in lipid profile or inflammatory markers in adult male Sprague-Dawley rats
It has not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA), nor has it been granted approval by the European Medicines Agency (EMA)
*Disclaimer: Mounjaro and Zepbound are both registered trademarks of Eli Lilly